Search results for: 'antibody deaco and alliance of 2022'
- Did you mean
- antibody deal and alliances of 2022
- Related search terms
- antibody deaco and alliance of 2021
- antibody deal and alliance of 2015
- antibody deaco and alliance of 2017
- antibody deaf and alliance of 2017
- antibody deaco and alliance of 2004
-
Molecular Diagnostics Collaboration and Licensing Deals 2016-2025May 2025$3,995.00Molecular Diagnostics Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2025
Learn More -
Infectious Vaccine Collaboration and Licensing Deals 2016-2025May 2025$3,995.00Infectious Vaccine Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2025
Learn More -
Gene Editing Collaboration and Licensing Deals 2016-2025May 2025$3,995.00Gene Editing Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2025
Learn More -
CP Knowledge CenterJuly 2025$14,995.00The All In One Partnering Intelligence Platform
Get unlimited access to our partnering report library conveniently and easily, while maximizing your time and budget
Learn More -
Stem Cell Collaboration and Licensing Deals 2010-2025May 2025$3,995.00Stem Cell Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2010 to 2025
Learn More -
Preclinical Stage Partnering Terms and Agreements in Pharmaceuticals and Biotechnology 2020-2025March 2025$4,995.00The Preclinical Stage Partnering Terms and Agreements in Pharma and Biotech (2020-2025) report offers in-depth insights and exclusive access to preclinical-stage partnering agreements signed by the world’s leading biopharma companies, providing a detailed analysis of deal structures, financial terms and strategic collaborations.
Learn More -
Genitourinary Collaboration and Licensing Deals 2016-2025April 2025$3,995.00Genitourinary Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2025
Learn More -
Bioinformatics Collaboration and Licensing Deals 2019-2025May 2025$3,995.00Bioinformatics Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2019 to 2025
Learn More -
Vaccine Collaboration and Licensing Deals 2016-2025May 2025$3,995.00Vaccine Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2025
Learn More -
Biomarker Collaboration and Licensing Deals 2016-2025May 2025$3,995.00Biomarker Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2025
Learn More
